Optimal Use of a Panel of Methylation Markers with the GSTP1 Hypermethylation in the Diagnosis of Prostate Adenocarcinoma

Abbreviated Name: Optimal Use of a Panel of Methylation Markers with the GSTP1 Hypermethylation in the Diagnosis of Pr

Protocol ID: 482

Lead Investigator: Sidransky, David — Johns Hopkins University School of Medicine

Coordinating Investigator: Sidransky, David — Johns Hopkins University School of Medicine

Involved Investigator Sites:

Biomarker Name: TIG1, APC, RARBeta2, GSTP1

Design: No design specified.

Field(s) of Research: UNKNOWN

Collaborative Group: Prostate and Urologic Cancers Research Group

Phased Status: 1

Abstract:

see publication

Aims: see publication

Analytic Method:

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

No datasets are currently associated with this protocol.